PEAK-1

A Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma

Arcus’ Phase 3 clinical trial for people with advanced clear cell renal cell carcinoma (a kind of kidney cancer) – PEAK-1 – will be enrolling soon.

Please fill out the form below to receive an email when a trial site near you may be open for enrollment.

Stay Informed About Clinical Trials

Participant Information

I am a...